Breast cancer screening is a recognized tool for early detection of the disease in
asymptomatic women, improving treatment efficacy and reducing the mortality rate. Multiple …

Breast cancer screening is widely recognized for reducing breast cancer mortality. The
objective in screening is to diagnose asymptomatic early stage disease, thereby improving …

Breast cancer is a heterogeneous disease that affects 1 in 8 women. Despite advances in
treatment and more widespread use of breast cancer screening, breast cancer remains the …

Breast cancer screening is used to identify women with asymptomatic cancer with the goal of
enabling women to undergo less invasive treatments that lead to better outcomes, ideally at …

Mammographic screening programmes aiming to reduce breast cancer mortality through
early detection and treatment have been established in many European countries. Meta …

Screening mammography reduces breast cancer mortality in average-risk women. However,
adverse consequences include false-positive findings possibly leading to benign breast …

The early detection of breast cancer with screening mammography in women who undergo
screening has been well-established in multiple trials to decrease mortality by more than …

Further progress in reducing breast cancer morbidity and mortality will require a better
understanding of methods for primary prevention, more effective therapy, and improved …

Breast cancer screening remains a subject of intense and, at times, passionate debate.
Mammography has long been the mainstay of breast cancer detection and is the only …

A decline in breast cancer mortality has been observed in western European Countries
since the middle of the 1990s. Different methodological approaches, including case-control …